Last reviewed · How we verify

Transversus abdominis plane block

Diskapi Yildirim Beyazit Education and Research Hospital · FDA-approved active Small molecule

A regional anesthesia technique that blocks nerve conduction in the transversus abdominis plane to provide anesthesia and analgesia to the abdominal wall.

A regional anesthesia technique that blocks nerve conduction in the transversus abdominis plane to provide anesthesia and analgesia to the abdominal wall. Used for Anesthesia and analgesia for abdominal surgery, Postoperative pain management following abdominal procedures.

At a glance

Generic nameTransversus abdominis plane block
Also known asMarcaine plain+morphine
SponsorDiskapi Yildirim Beyazit Education and Research Hospital
Drug classRegional anesthetic technique / Local anesthetic nerve block
ModalitySmall molecule
Therapeutic areaAnesthesia / Pain Management
PhaseFDA-approved

Mechanism of action

The transversus abdominis plane (TAP) block is a peripheral nerve block that delivers local anesthetic to the plane between the internal oblique and transversus abdominis muscles, where the thoracolumbar nerves run. This blocks sensory innervation to the abdominal wall, providing anesthesia during surgery and postoperative pain relief. It is administered via ultrasound-guided injection and is commonly used as part of multimodal anesthesia for abdominal procedures.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: